Disc Medicine, Inc. (IRON)
(Delayed Data from NSDQ)
$51.74 USD
+1.39 (2.76%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $51.75 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Brokerage Reports
0 items in cart
Disc Medicine, Inc. [IRON]
Reports for Purchase
Showing records 1 - 20 ( 47 total )
Company: Disc Medicine, Inc.
Industry: Unclassified
Clarification Of Regulatory Pathways For The Key Programs In The Coming Months; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Disc Medicine, Inc.
Industry: Unclassified
Company: Disc Medicine, Inc.
Industry: Unclassified
Company: Disc Medicine, Inc.
Industry: Unclassified
Updated EPP Data Analyses Support the Program Going Forward; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Disc Medicine, Inc.
Industry: Unclassified
Company: Disc Medicine, Inc.
Industry: Unclassified
Company: Disc Medicine, Inc.
Industry: Unclassified
Top 16 Takeaways From Our Coverage at the H.C. Wainwright Bioconnect Conference
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Disc Medicine, Inc.
Industry: Unclassified
Additional Analysis of AURORA Should Provide More Clarity; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Disc Medicine, Inc.
Industry: Unclassified
See AURORA Outside in June, and Inside FDA in H2
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Disc Medicine, Inc.
Industry: Unclassified
Company: Disc Medicine, Inc.
Industry: Unclassified
Our Confidence in Bitopertin''s Path Forward Remains Unbowed; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Disc Medicine, Inc.
Industry: Unclassified
AURORA Meets Primary Endpoint But Misses on Key Secondary Endpoint With Placebo Surprise
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Disc Medicine, Inc.
Industry: Unclassified
Company: Disc Medicine, Inc.
Industry: Unclassified
Company: Disc Medicine, Inc.
Industry: Unclassified
Waiting For AURORA as the Pipeline Begins to Broaden; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Disc Medicine, Inc.
Industry: Unclassified
Company: Disc Medicine, Inc.
Industry: Unclassified
Company: Disc Medicine, Inc.
Industry: Unclassified
Company: Disc Medicine, Inc.
Industry: Unclassified
ASH Brings Key Program Updates and We See Plenty of Upside From Here; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D